India takes on western firms in battle to protect home remedies

Western firms are accused of trying to patent common treatments, but the government is hitting back on an issue of national pride.

Indian women attend the Ayurvedic fair in Hyderabad. For centuries, Indian housewives have used homemade remedies.
Powered by automated translation

NEW DELHI // For centuries, Indian housewives have used homemade remedies based on cow's milk to cure constipation, but in 2009 the Swiss food giant Nestle applied for a patent to protect a similar product of its own.

Earlier this year, India successfully fought off Nestle's attempt at the European Patent Office (EPO) to secure a patent, saying that using cow's milk as a laxative was mentioned in ancient texts and was therefore not new.

Indian government officials are fighting hundreds of other cases to try to protect the country's "genetic heritage", a topic high on the agenda at the UN's Convention on Biological Diversity currently meeting in Hyderabad.

"India is one of the mega centres for biodiversity in the world," said Vinod Bhatt, the director of research at Navdanya, a non-profit body that seeks to promote indigenous knowledge.

"We cannot allow theft of our traditional knowledge that dates back thousands of years and is rooted in our culture. We have to protect ourselves from commercial exploitation by the western world."

Traditional knowledge, used for centuries by indigenous communities under local laws and customs, plays an important role in areas such as food security, biodiversity, agriculture and medicine.

"Nestle is just one case. We have already succeeded in 110, and 800 more are in the pipeline," said he head of India's Traditional Knowledge Digital Library (TKDL), Vinod Kumar Gupta.

The library is a database established in 2001 that has recorded more than 250,000 traditional formulations, including the ayurvedic system of medicine that has become hugely popular in the West.

"Every known medicinal plant in India is under piracy attack," said Mr Gupta, citing an example where a US patent application was made by the Britain-based firm Provexis on the use of banana extracts as treatment for diarrhoea.

Evidence from the TKDL proved the banana preparation was previously well known, and the application was withdrawn.

In the cow's milk case, the European patent authorities also sought advice from the database which confirmed it was a remedy - often mixed with other ingredients - to treat constipation for hundreds of years.

A patent application is normally rejected if there is "prior existing knowledge" about the product, but that is far easier to prove if the information is published in a journal or on a database, rather than only held in folklore.

About 200 researchers took eight years to create the TKDL database, combing through Hindi, Sanskrit, Arabic, Persian and Urdu texts on ayurveda, yoga and other less-known health systems such as unani and siddha.

The TKDL is accessible to foreign patent offices, which can consult it before deciding whether to grant exclusive rights to applicants.

India woke up to the threat of what is now termed "biopiracy" 20 years ago after a European patent was granted to a US group on an anti-fungal product derived from the native Indian neem tree.

Campaigners and Green Party politicians in Europe challenged its validity, and in 2000 India finally won a 10-year legal battle to have the patent revoked as neem seeds had been used for centuries as a medicine, insecticide and contraceptive.

In 2009, the EPO also withdrew another patent granted to a Spanish company for the use of melon extract to treat the skin disease vitiligo on the same legal grounds.

The practical effect of patents may in reality have little effect in India's villages, where plants, trees and other natural products are still widely used to treat maladies.

But the patents provoke an angry response from the government, which sees protecting knowledge of traditional Indian medicine from foreign commercial exploitation as a matter of national pride.

Legal battles between the TKDL and global firms over patent requests can take years to resolve and require exhaustive documentation by the agency's researchers to prove prior art references.

Scientists and lawyers agree that countries such as India must be more vigilant.

"Between 1992 and 2000 China revised its patent laws twice to ensure that it could draw intellectual property control over its unique system of medicine," said agriculture scientist and biodiversity expert, Devinder Sharma.

He said similar legislation must be put in place in India. Lawyers backed Mr Sharma's idea and called for comprehensive laws to provide better protection from the international patents.

"Traditional knowledge falls into the grey area and is not as clearly defined as intellectual property rights in Indian law," said Pratiush Pratik, a New Delhi-based lawyer who specialises in the subject.

Western societies have accepted the loss of traditional knowledge, he said. "India must not make that mistake."